HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population.

Abstract
Enterolignans are phytoestrogenic compounds derived from the conversion of dietary lignans by the intestinal microflora that may be protective against cardiovascular diseases and cancer. To evaluate the use of enterolignans as biomarkers of dietary lignan intake, we studied the relation between plasma and dietary lignans. We determined the dietary intake of 4 lignans (secoisolariciresinol (SECO), matairesinol (MAT), pinoresinol, and lariciresinol) using the European Prospective Investigation into Cancer and Nutrition FFQ, and plasma enterodiol (END) and enterolactone (ENL) concentrations were determined by liquid chromatography-tandem mass spectrometry. The population consisted of 637 men and women, aged 19-75 y, participating in a case-control study on colorectal adenomas. Participants did not use antibiotics in the preceding calendar year. We found a modest association between lignan intake and plasma END (Spearman r = 0.09, P = 0.03) and ENL (Spearman r = 0.18, P <0.001). The correlation of total lignan intake with plasma enterolignans was slightly stronger than that of only SECO plus MAT. The plasma concentrations of both END and ENL were associated with intake of dietary fiber and vegetable protein but not with intake of other macronutrients. The relation between lignan intake and plasma END was modulated by age and previous use of antibiotics, whereas for ENL, it was modulated by weight, current smoking, and frequency of defecation. However, even when we included these nondietary factors in the regression models, the explained variance in plasma END and ENL remained low (2 and 13%, respectively).
AuthorsIvon E J Milder, Anneleen Kuijsten, Ilja C W Arts, Edith J M Feskens, Ellen Kampman, Peter C H Hollman, Pieter Van 't Veer
JournalThe Journal of nutrition (J Nutr) Vol. 137 Issue 5 Pg. 1266-71 (May 2007) ISSN: 0022-3166 [Print] United States
PMID17449591 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lignans
  • Phytoestrogens
  • 2,3-bis(3'-hydroxybenzyl)butane-1,4-diol
  • 4-Butyrolactone
  • 2,3-bis(3'-hydroxybenzyl)butyrolactone
Topics
  • 4-Butyrolactone (analogs & derivatives, blood)
  • Adenomatous Polyps (blood, diagnosis)
  • Adult
  • Aged
  • Case-Control Studies
  • Colonoscopy
  • Colorectal Neoplasms (blood, diagnosis)
  • Diet
  • Female
  • Humans
  • Lignans (administration & dosage, blood)
  • Male
  • Middle Aged
  • Phytoestrogens (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: